DK304183D0 - Thieno (3,2-c) pyridinderivater og fremgangsmade til fremstilling deraf - Google Patents

Thieno (3,2-c) pyridinderivater og fremgangsmade til fremstilling deraf

Info

Publication number
DK304183D0
DK304183D0 DK3041/83A DK304183A DK304183D0 DK 304183 D0 DK304183 D0 DK 304183D0 DK 3041/83 A DK3041/83 A DK 3041/83A DK 304183 A DK304183 A DK 304183A DK 304183 D0 DK304183 D0 DK 304183D0
Authority
DK
Denmark
Prior art keywords
group
lower alkyl
pyridine derivatives
image
thieno
Prior art date
Application number
DK3041/83A
Other languages
English (en)
Other versions
DK157552B (da
DK304183A (da
DK157552C (da
Inventor
Daniel Aubert
Claude Ferrand
Jean-Pierre Maffrand
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK304183D0 publication Critical patent/DK304183D0/da
Publication of DK304183A publication Critical patent/DK304183A/da
Publication of DK157552B publication Critical patent/DK157552B/da
Application granted granted Critical
Publication of DK157552C publication Critical patent/DK157552C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
DK304183A 1982-07-13 1983-07-01 Analogifremgangsmaade til fremstilling af thieno (3,2-c) pyridinderivater DK157552C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8212599A FR2530247B1 (fr) 1982-07-13 1982-07-13 Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR8212599 1982-07-13

Publications (4)

Publication Number Publication Date
DK304183D0 true DK304183D0 (da) 1983-07-01
DK304183A DK304183A (da) 1984-01-14
DK157552B DK157552B (da) 1990-01-22
DK157552C DK157552C (da) 1990-06-11

Family

ID=9276096

Family Applications (1)

Application Number Title Priority Date Filing Date
DK304183A DK157552C (da) 1982-07-13 1983-07-01 Analogifremgangsmaade til fremstilling af thieno (3,2-c) pyridinderivater

Country Status (33)

Country Link
US (1) US4529596A (da)
EP (1) EP0099802B1 (da)
JP (1) JPS5927895A (da)
KR (1) KR870001270B1 (da)
AT (1) ATE25384T1 (da)
AU (1) AU554358B2 (da)
CA (1) CA1194875A (da)
CS (1) CS246062B2 (da)
DD (1) DD211351A5 (da)
DE (1) DE3369683D1 (da)
DK (1) DK157552C (da)
DZ (1) DZ558A1 (da)
EG (1) EG16540A (da)
ES (1) ES8403901A1 (da)
FI (1) FI73218C (da)
FR (1) FR2530247B1 (da)
GR (1) GR79592B (da)
HU (1) HU187111B (da)
IE (1) IE55895B1 (da)
IL (1) IL69049A (da)
MA (1) MA19843A1 (da)
MX (1) MX9203264A (da)
NO (1) NO159725C (da)
NZ (1) NZ204874A (da)
OA (1) OA07491A (da)
PH (1) PH19375A (da)
PL (1) PL142272B1 (da)
PT (1) PT77018B (da)
SG (1) SG95287G (da)
SU (1) SU1272994A3 (da)
UA (1) UA7142A1 (da)
YU (2) YU44384B (da)
ZA (1) ZA834705B (da)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8429087D0 (en) * 1984-11-16 1984-12-27 Scras Thienopyridine derivatives
FR2576901B1 (fr) * 1985-01-31 1987-03-20 Sanofi Sa Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique
FR2596392B1 (fr) * 1986-03-27 1988-08-05 Sanofi Sa Derives de l'acide a-(hydroxy-3 oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenylacetique, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2597102B1 (fr) * 1986-04-14 1988-08-26 Sanofi Sa Derives de l'acide a-(hydroxy-7 tetrahydro-4,5,6,7 thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2612929B1 (fr) * 1987-02-17 1990-02-09 Sanofi Sa Enantiomere dextrogyre de 1a-(tetrahydro- 4,5,6,7 thieno (3,2-c) pyridyl-5) (chloro-2 phenyl)-acetate de methyle, son procede de preparation et les compositions pharmaceutiques le renfermant
JPH0339159A (ja) * 1989-07-07 1991-02-20 Toichi Chikuma 健康用具
US5189170A (en) * 1989-09-29 1993-02-23 Sanofi Process for the preparation of phenylacetic derivatives of thieno-pyridines
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
JPH03242154A (ja) * 1990-02-17 1991-10-29 Toichi Chikuma 健康用具
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
FR2672801B1 (fr) * 1991-02-14 1995-03-03 Sanofi Sa Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese.
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
NZ334389A (en) * 1996-08-28 2001-05-25 Ube Industries Cyclic amine derivatives
HU225503B1 (en) * 1997-05-13 2007-01-29 Sanofi Aventis Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
HU225504B1 (en) * 1997-05-13 2007-01-29 Sanofi Aventis Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
HU222283B1 (hu) * 1997-05-13 2003-05-28 Sanofi-Synthelabo Eljárás tieno[3,2-c]piridin-származékok előállítására
FR2769313B1 (fr) 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
ATE238279T1 (de) 1998-02-27 2003-05-15 Sankyo Co Zyklische aminoverbindungen
JP4588877B2 (ja) 1998-06-17 2010-12-01 ブリストル−マイヤーズ スクイブ カンパニー Ａｄｐ−受容体抗血小板物質と抗高血圧薬の組合せ投与による脳梗塞の予防
HU226421B1 (en) * 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
WO2000054811A1 (fr) 1999-03-17 2000-09-21 Daiichi Pharmaceutical Co., Ltd. Compositions medicamenteuses
KR100692934B1 (ko) * 2000-12-25 2007-03-12 상꾜 가부시키가이샤 아스피린을 함유하는 의약 조성물
ATE349451T1 (de) * 2001-01-24 2007-01-15 Cadila Healthcare Ltd Verfahren zur herstellung von clopidogrel
IN191030B (da) 2001-01-24 2003-09-13 Cadila Healthcare Ltd
CA2352520C (en) * 2001-07-06 2007-10-02 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
ITMI20020933A1 (it) * 2002-05-03 2003-11-03 Danimite Dipharma S P A Procedimento per la sintesi di clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
WO2004031143A2 (en) * 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
US6812363B2 (en) * 2002-10-15 2004-11-02 Usv Limited Racemization of optically active 2-substituted phenyl glycine esters
ITMI20022228A1 (it) * 2002-10-21 2004-04-22 Dinamite Dipharma S P A Sali di clopidogrel con acidi alchil-solforici.
EP1606231A1 (en) * 2003-02-03 2005-12-21 Nadkarni, Sunil Sadanand Process for preparation of clopidogrel, its salts and pharmaceutical compositions
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
AU2003238664A1 (en) 2003-03-12 2004-09-30 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
EP1618111B1 (en) 2003-04-25 2014-12-24 Cadila Healthcare Limited Salts of clopidogrel and process for preparation
DE10337773A1 (de) * 2003-08-13 2005-03-24 Krka Tovarna Zdravil, D.D. Kristallisation von festen Formen von Clopidogrel-Additionssalzen
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
WO2005063708A2 (en) 2003-11-03 2005-07-14 Cadila Healthcare Limited Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate
CA2454015C (en) * 2003-12-23 2009-11-24 Brantford Chemicals Inc. A process for the preparation of tetrahydrothieno [3,2-c] pyridine derivatives
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
WO2005117866A1 (en) * 2004-06-01 2005-12-15 Ivax Pharmaceuticals S.R.O. Amorphous clopidogrel hydrochloride and its antithrombotic use
AR050631A1 (es) * 2004-09-09 2006-11-08 Novartis Ag Combinacion de compuestos organicos
WO2006034451A2 (en) * 2004-09-21 2006-03-30 Teva Pharmaceutical Industries Ltd. Crystalline clopidogrel hydrobromide and processes for preparation thereof
CA2594763A1 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
CZ299213B6 (cs) 2005-03-08 2008-05-21 Zentiva, A. S Zpusob racemizace R(-) izomeru methylesteru kyseliny (2-chlorfenyl)-6,7-dihydro-thieno[3,2-c]pyridin-5(4H)-octové
WO2006130852A1 (en) * 2005-06-02 2006-12-07 Dr. Reddy's Laboratories Ltd. Recovery of clopidogrel bisulfate
EP1902058A2 (en) 2005-07-12 2008-03-26 RPG Life Sciences Limited A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
WO2007029096A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Novel polymorphic forms of clopidogrel hydrochloride
WO2007052300A2 (en) 2005-09-05 2007-05-10 Cadila Healthcare Limited Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate
WO2007029080A1 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Preparation of form i of clopidogrel hydrochloride
CN100390180C (zh) * 2005-12-15 2008-05-28 上海应用技术学院 氯吡格雷及其盐的制备方法
KR101235117B1 (ko) * 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR100742134B1 (ko) * 2006-02-07 2007-07-24 경동제약 주식회사 결정성Ｓ-(+)-메틸-2-(2-클로로페닐)-2-(6,7-디히드로티에노[3,2-ｃ]피리딘-5(4Ｈ)-일)아세테이트·캄실레이트를 포함하는약학적 조성물
WO2007115305A2 (en) 2006-04-04 2007-10-11 Cogentus Pharmaceuticals, Inc. Oral dosage forms including an antiplatelet agent and an acid inhibitor
JP2009543759A (ja) * 2006-04-27 2009-12-10 アイエヌディー−スイフト ラボラトリーズ リミテッド クロピドグレル硫酸水素塩の多形相を調製するプロセス
PT2064217E (pt) * 2006-09-04 2011-04-19 Ranbaxy Lab Ltd Processo melhorado para a preparação de clopidogrel e seus sais farmaceuticamente aceitáveis
EP1900358A1 (en) 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel
US20100062066A1 (en) * 2006-11-14 2010-03-11 Acusphere, Inc Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
MX2008016012A (es) * 2007-04-18 2009-03-06 Teva Pharma Proceso mejorado para preparar clopidogrel.
DK2152078T3 (da) 2007-04-27 2021-02-08 Cydex Pharmaceuticals Inc Formuleringer indeholdende clopidogrel og sulfoalkylethercyclodextrin og anvendelsesfremgangsmåder
EP2155756B1 (en) * 2007-05-30 2015-08-05 Wockhardt Limited Processes for the preparation of clopidogrel
WO2009080469A1 (en) * 2007-12-24 2009-07-02 Sandoz Ag Process for the preparation of clopidogrel bisulphate form i
ATE530172T1 (de) 2008-02-26 2011-11-15 Lesvi Laboratorios Sl Pharmazeutische formulierungen mit clopidogrel
RU2010144554A (ru) * 2008-04-01 2012-05-10 Астеллас Фарма Инк. (Jp) Средство для предотвращения и/или лечения сосудистых заболеваний
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
US9427448B2 (en) 2009-11-11 2016-08-30 The Medicines Company Methods of treating, reducing the incidence of, and/or preventing ischemic events
WO2009140092A1 (en) * 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20120141468A1 (en) 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
US8759316B2 (en) * 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20130303477A1 (en) * 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
KR100990949B1 (ko) 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
US8299097B2 (en) * 2008-09-12 2012-10-30 The Brigham And Women's Hospital, Inc. Methods for treating inflammatory disorders
CN102186858A (zh) * 2008-10-24 2011-09-14 桑多斯股份公司 制备s-氯吡格雷的方法
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN101402641B (zh) * 2008-11-20 2011-05-04 天津药物研究院 含噻吩并吡啶的肟类衍生物、其制备方法和用途
US20120121706A1 (en) 2009-04-10 2012-05-17 Tufts Medical Center, Inc. PAR-1 Activation by Metalloproteinase-1 (MMP-1)
DK3100728T3 (da) 2009-05-13 2020-02-17 Cydex Pharmaceuticals Inc Farmaceutiske sammensætninger omfattende prasugrel og cyclodextrin-derivativ og fremgangsmåder til fremstilling og brug af samme
NZ597510A (en) 2009-06-25 2012-12-21 Tetra Sia NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium
CN101585842B (zh) * 2009-07-13 2011-07-20 北京赛科药业有限责任公司 氯吡格雷中杂质b的研究及控制方法
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
PT2498731T (pt) 2009-11-11 2020-02-21 Chiesi Farm Spa Métodos de tratamento ou prevenção de uma trombose de endoprótese
WO2011101865A2 (en) 2010-02-19 2011-08-25 Cadila Healthcare Limited Stable pharmaceutical compositions of clopidogrel for parenteral delivery
CN102212069A (zh) * 2010-04-06 2011-10-12 刘桂坤 环烷衍生物及其制备方法和在心脑血管病药物上的应用
CN101812071A (zh) * 2010-05-10 2010-08-25 杭州和素化学技术有限公司 硫酸氢氯吡格雷中间体拆分后的母液处理方法
CN102241690B (zh) 2010-05-13 2015-08-12 天津药物研究院 一类含腈基的噻吩并吡啶酯类衍生物、其制备方法和用途
CN101863901B (zh) * 2010-06-29 2012-12-05 天津药物研究院 2-(取代苯基)-2-(4,5,6,7-四氢噻吩并[3,2-c]吡啶-5(4H)-基)-N-取代-乙酰胺、其制备方法和用途
WO2012007019A1 (en) 2010-07-13 2012-01-19 Pharmathen S.A. Process for the preparation of clopidogrel and salts thereof
MX349974B (es) 2010-08-26 2017-08-22 Ipca Laboratories Ltd * Metodo para el tratamiento o profilaxis de trombosis o embolismo.
CN101974015B (zh) * 2010-10-11 2012-05-09 天津药物研究院 酯类化合物、其制备方法和用途
CN101974016A (zh) * 2010-10-14 2011-02-16 天津药物研究院 酰胺类化合物及其制备方法和用途
CN101962388B (zh) * 2010-10-14 2012-12-19 天津药物研究院 乙酰胺衍生物及其制备方法和用途
LT2629776T (lt) * 2010-10-18 2017-11-10 Cerenis Therapeutics Holding Sa Junginiai, kompozicijos ir būdai, tinkami cholesterolio mobilizavimui
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
US20120329762A1 (en) 2011-06-27 2012-12-27 Ashok Kumar Anti-thrombotic compounds
EP2750676B1 (en) 2011-08-30 2018-01-10 University of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
AU2012349771A1 (en) 2011-12-09 2014-07-03 Wockhardt Limited Methods for treating cardiovascular disorder
CN103665042B (zh) * 2012-09-21 2016-03-16 北京普禄德医药科技有限公司 光学活性的2-羟基四氢噻吩并吡啶衍生物及其制备方法和用途
CN102993210A (zh) * 2012-12-19 2013-03-27 苏春华 一种吡啶并噻吩的新化合物
WO2014118802A1 (en) 2013-01-31 2014-08-07 Pharmazell Gmbh An improved process for the preparation of clopidogrel bisulfate form-i
CN104447867B (zh) * 2013-09-17 2017-12-26 江苏天士力帝益药业有限公司 一种噻吩并哌啶衍生物、制备方法及其应用
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
CA3060345A1 (en) 2017-06-23 2018-12-27 Chiesi Farmaceutici S.P.A. Method of preventing of systemic-to-pulmonary-artery shunt thrombosis
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
WO2023012479A1 (en) 2021-08-03 2023-02-09 Liqmeds Worldwide Limited An oral pharmaceutical solution of clopidogrel
CN115260086A (zh) * 2022-09-28 2022-11-01 吉林大学 一种氟代内标物及其应用和制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2527574A (en) * 1948-06-01 1950-10-31 Parke Davis & Co Esters of phenyl-heterocyclicaminoacetic acid and their production
FR1312412A (fr) * 1959-12-18 1962-12-21 Dausse Lab Dérivés de l'acide alpha-phényl alpha-pipéridino acétique et leur préparation
FR2215948B1 (da) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma

Also Published As

Publication number Publication date
PT77018A (fr) 1983-08-01
NO832530L (no) 1984-01-16
PH19375A (en) 1986-04-02
DZ558A1 (fr) 2004-09-13
FR2530247A1 (fr) 1984-01-20
SU1272994A3 (ru) 1986-11-23
DK157552B (da) 1990-01-22
EP0099802A1 (fr) 1984-02-01
FR2530247B1 (fr) 1986-05-16
US4529596A (en) 1985-07-16
YU45291B (en) 1992-05-28
YU44384B (en) 1990-06-30
YU150683A (en) 1986-04-30
CS246062B2 (en) 1986-10-16
MA19843A1 (fr) 1984-04-01
PT77018B (fr) 1986-01-24
FI832543A0 (fi) 1983-07-12
CA1194875A (fr) 1985-10-08
AU554358B2 (en) 1986-08-21
AU1663783A (en) 1984-01-19
YU197485A (en) 1986-10-31
IE831604L (en) 1984-01-13
FI73218C (fi) 1987-09-10
ZA834705B (en) 1984-03-28
EG16540A (en) 1990-12-30
OA07491A (fr) 1985-03-31
CS528183A2 (en) 1985-12-16
PL142272B1 (en) 1987-10-31
JPS64955B2 (da) 1989-01-10
JPS5927895A (ja) 1984-02-14
IE55895B1 (en) 1991-02-14
KR870001270B1 (ko) 1987-06-30
ES523943A0 (es) 1984-04-01
IL69049A0 (en) 1983-10-31
GR79592B (da) 1984-10-31
NO159725C (no) 1989-02-01
HU187111B (en) 1985-11-28
IL69049A (en) 1986-03-31
DE3369683D1 (en) 1987-03-12
FI832543L (fi) 1984-01-14
DD211351A5 (de) 1984-07-11
DK304183A (da) 1984-01-14
PL242965A1 (en) 1984-07-16
ES8403901A1 (es) 1984-04-01
MX9203264A (es) 1992-07-01
UA7142A1 (uk) 1995-06-30
ATE25384T1 (de) 1987-02-15
EP0099802B1 (fr) 1987-02-04
SG95287G (en) 1990-11-23
NO159725B (no) 1988-10-24
DK157552C (da) 1990-06-11
NZ204874A (en) 1986-01-24
FI73218B (fi) 1987-05-29
KR840005448A (ko) 1984-11-12

Similar Documents

Publication Publication Date Title
DK304183A (da) Thieno (3,2-c) pyridinderivater og fremgangsmaade til fremstilling deraf
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
DK9185D0 (da) Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf
ES8207180A1 (es) Procedimiento de fabricacion de derivados de tetrahidro-5,67,7a 4h-tieno (3,2-c) piridinona-2 .
IE831407L (en) THIENO £3,2-c| PYRIDINE DERIVATIVES
SE7605899L (sv) Forfarande for framstellning av tienopyridinderivat
ES8702399A1 (es) Un procedimiento para preparar derivdos de 1,5-benzoxatiepina
ZA81863B (en) 5,6; 8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives, the preparation thereof and compositions
ES2042727T3 (es) Acidos 1,3,4,9-tetrahidropirano(3,4-b)indol-1-acetico.
SE8301785L (sv) Sett att framstella 2-tiofen-ettiksyraderivat och mellanprodukter erforderliga for deras framstellning
SE7811761L (sv) 4,5,6,7-tetrahydroimidazo-(4,5-c),pyridinderivat och forfarande for deras framstellning
JPS51136698A (en) Process for preparing new pyridone carboxylic acid derivatives

Legal Events

Date Code Title Description
PUP Patent expired